Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Augmented transgene expression in transformed cells using a parvoviral hybrid vector

Cancer Gene Therapy volume 15, pages 252–267 (2008)Cite this article

Abstract

Autonomous parvoviruses possess an intrinsic oncotropism based on viral genetic elements controlling gene expression and genome replication. We constructed a hybrid vector consisting of the H1 parvovirus-derived expression cassette comprising the p4 promoter, the ns1 gene and the p38 promoter flanked by the adeno-associated viruses 2 (AAV2) inverted terminal repeats and packaged into AAV2 capsids. Gene transduction using this vector could be stimulated by coinfection with adenovirus, by irradiation or treatment with genotoxic agents, similar to standard AAV2 vectors. However, the latter were in most cases less efficient in gene transduction than the hybrid vector. With the new vector, tumor cell-selective increase in transgene expression was observed in pairs of transformed and non-transformed cells, leading to selective killing of the transformed cells after expression of a prodrug-converting enzyme. Preferential gene expression in tumor versus normal liver tissue was also observed in vivo in a syngeneic rat model. Comparative transduction of a panel of different tumor cell lines with the H1 and the H1/AAV hybrid vector showed a preference of each vector for distinct cell types, probably reflecting the dependence of the viral tropism on capsid determinants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Muzyczka N, Warrington Jr KH . Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism. Hum Gene Ther 2005; 16: 408–416.

    Article  CAS  PubMed  Google Scholar 

  2. Buning H, Ried MU, Perabo L, Gerner FM, Huttner NA, Enssle J et al. Receptor targeting of adeno-associated virus vectors. Gene Therapy 2003; 10: 1142–1151.

    Article  CAS  PubMed  Google Scholar 

  3. Wickham TJ . Ligand-directed targeting of genes to the site of disease. Nat Med 2003; 9: 135–139.

    Article  CAS  PubMed  Google Scholar 

  4. Waterkamp DA, Muller OJ, Ying Y, Trepel M, Kleinschmidt JA . Isolation of targeted AAV2 vectors from novel virus display libraries. J Gene Med 2006; 8: 1307–1319.

    Article  CAS  PubMed  Google Scholar 

  5. Khare PD, Rosales AG, Bailey KR, Russell SJ, Federspiel MJ . Epitope selection from an uncensored peptide library displayed on avian leukosis virus. Virology 2003; 315: 313–321.

    Article  CAS  PubMed  Google Scholar 

  6. Bupp K, Roth MJ . Targeting a retroviral vector in the absence of a known celltargeting ligand. Hum Gene Therapy 2003; 14: 1557–1564.

    Article  CAS  Google Scholar 

  7. Hartl I, Schneider RM, Sun Y, Medvedovska J, Chadwick MP, Russell SJ et al. Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells. Gene Therapy 2005; 12: 918–926.

    Article  CAS  PubMed  Google Scholar 

  8. Muller OJ, Kaul F, Weitzman MD, Pasqualini R, Arap W, Kleinschmidt JA et al. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 2003; 21: 1040–1046.

    Article  PubMed  CAS  Google Scholar 

  9. Perabo L, Buning H, Kofler DM, Ried MU, Girod A, Wendtner CM et al. In vitro selection of viral vectors with modified tropism: the adeno-associated virus display. Mol Ther 2003; 8: 151–157.

    Article  CAS  PubMed  Google Scholar 

  10. Kottke T, Qiao J, Diaz RM, Ahmed A, Vroman B, Thompson J et al. The perforindependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles. Gene Therapy 2006; 13: 1166–1177.

    Article  CAS  PubMed  Google Scholar 

  11. Cole C, Qiao J, Kottke T, Diaz RM, Ahmed A, Sanchez-Perez L et al. Tumortargeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigenspecific T cells. Nat Med 2005; 11: 1073–1081.

    Article  CAS  PubMed  Google Scholar 

  12. Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, James CD et al. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 2005; 23: 209–214.

    Article  CAS  PubMed  Google Scholar 

  13. Toniatti C, Bujard H, Cortese R, Ciliberto G . Gene therapy progress and prospects: transcription regulatory systems. Gene Therapy 2004; 11: 649–657.

    Article  CAS  PubMed  Google Scholar 

  14. Nettelbeck DM, Jerome V, Muller R . Gene therapy: designer promoters for tumour targeting. Trends Genet 2000; 16: 174–181.

    Article  CAS  PubMed  Google Scholar 

  15. Dupont F, Avalosse B, Karim A, Mine N, Bosseler M, Maron A et al. Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector. Gene Therapy 2000; 7: 790–796.

    Article  CAS  PubMed  Google Scholar 

  16. Gancberg D, Zeicher M, Bakkus M, Dupont F, Leo O, Moser M et al. Oncoselective transduction of CD80 and CD86 in tumor cell lines using an autonomous recombinant parvovirus. Anticancer Res 2000; 20: 1825–1832.

    CAS  PubMed  Google Scholar 

  17. Russell SJ, Brandenburger A, Flemming CL, Collins MK, Rommelaere J . Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus. J Virol 1992; 66: 2821–2828.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cornelis JJ, Salome N, Dinsart C, Rommelaere J . Vectors based on autonomous parvoviruses: novel tools to treat cancer? J Gene Med 2004; 6 (Suppl 1): S193–S202.

    Article  CAS  PubMed  Google Scholar 

  19. Roberts MS, Lorence RM, Groene WS, Bamat MK . Naturally oncolytic viruses. Curr Opin Mol Ther 2006; 8: 314–321.

    PubMed  Google Scholar 

  20. Chiocca EA . Oncolytic viruses. Nat Rev Cancer 2002; 2: 938–950.

    Article  PubMed  CAS  Google Scholar 

  21. Russell SJ . RNA viruses as virotherapy agents. Cancer Gene Ther 2002; 9: 961–966.

    Article  CAS  PubMed  Google Scholar 

  22. Liu XY . Targeting gene-virotherapy of cancer and its prosperity. Cell Res 2006; 16: 879–886.

    Article  CAS  PubMed  Google Scholar 

  23. Cornelis JJ, Lang SI, Stroh-Dege AY, Balboni G, Dinsart C, Rommelaere J . Cancer gene therapy through autonomous parvovirus-mediated gene transfer. Curr Gene Ther 2004; 4: 249–261.

    Article  CAS  PubMed  Google Scholar 

  24. Maxwell IH, Terrell KL, Maxwell F . Autonomous parvovirus vectors. Methods 2002; 28: 168–181.

    Article  CAS  PubMed  Google Scholar 

  25. Blechacz B, Russell SJ . Parvovirus vectors: use and optimisation in cancer gene therapy. Expert Rev Mol Med 2004; 6: 1–24.

    Article  PubMed  Google Scholar 

  26. Rommelaere J, Cornelis JJ . Antineoplastic activity of parvoviruses. J Virol Methods 1991; 33: 233–251.

    Article  CAS  PubMed  Google Scholar 

  27. McKisic MD, Paturzo FX, Smith AL . Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation 1996; 61: 292–299.

    Article  CAS  PubMed  Google Scholar 

  28. Perros M, Deleu L, Vanacker JM, Kherrouche Z, Spruyt N, Faisst S et al. Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells. J Virol 1995; 69: 5506–5515.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Fuks F, Deleu L, Dinsart C, Rommelaere J, Faisst S . ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors. J Virol 1996; 70: 1331–1339.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Deleu L, Fuks F, Spitkovsky D, Horlein R, Faisst S, Rommelaere J . Opposite transcriptional effects of cyclic AMP-responsive elements in confluent or p27KIP overexpressing cells versus serum-starved or growing cells. Mol Cell Biol 1998; 18: 409–419.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Warrington Jr KH, Herzog RW . Treatment of human disease by adeno-associated viral gene transfer. Hum Genet 2006; 119: 571–603.

    Article  CAS  PubMed  Google Scholar 

  32. Ponnazhagan S, Curiel DT, Shaw DR, Alvarez RD, Siegal GP . Adeno-associated virus for cancer gene therapy. Cancer Res 2001; 61: 6313–6321.

    CAS  PubMed  Google Scholar 

  33. Li C, Bowles DE, van Dyke T, Samulski RJ . Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther 2005; 12: 913–925.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Pear WS, Nolan GP, Scott ML, Baltimore D . Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392–8396.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Salvetti A, Oreve S, Chadeuf G, Favre D, Cherel Y, Champion-Arnaud P et al. Factors influencing recombinant adeno-associated virus production. Hum Gene Ther 1998; 9: 695–706.

    Article  CAS  PubMed  Google Scholar 

  36. Chen YQ, de Foresta F, Hertoghs J, Avalosse BL, Cornelis JJ, Rommelaere J . Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1. Cancer Res 1986; 46: 3574–3579.

    CAS  PubMed  Google Scholar 

  37. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE . Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761–771.

    Article  CAS  PubMed  Google Scholar 

  38. Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE . c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 1990; 50: 2840–2847.

    CAS  PubMed  Google Scholar 

  39. Soule HD, Vazguez J, Long A, Albert S, Brennan M . A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 1973; 51: 1409–1416.

    Article  CAS  PubMed  Google Scholar 

  40. Kalkhoven E, Roelen BA, de Winter JP, Mummery CL, van den Eijnden-van Raaij AJ, van der Saag PT et al. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ 1995; 6: 1151–1161.

    CAS  PubMed  Google Scholar 

  41. Ohnuki Y, Marnell MM, Babcock MS, Lechner JF, Kaighn ME . Chromosomal analysis of human prostatic adenocarcinoma cell lines. Cancer Res 1980; 40: 524–534.

    CAS  PubMed  Google Scholar 

  42. McAllister RM, Isaacs H, Rongey R, Peer M, Au W, Soukup SW et al. Establishment of a human medulloblastoma cell line. Int J Cancer 1977; 20: 206–212.

    Article  CAS  PubMed  Google Scholar 

  43. Kestler J, Neeb B, Struyf S, Van Damme J, Cotmore SF, D'Abramo A et al. cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses. Hum Gene Ther 1999; 10: 1619–1632.

    Article  CAS  PubMed  Google Scholar 

  44. Zolotukhin S, Potter M, Hauswirth WW, Guy J, Muzyczka N . A ‘humanized’ green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646–4654.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Heilbronn R, Burkle A, Stephan S, zur Hausen H . The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification. J Virol 1990; 64: 3012–3018.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Groner B, Herrlich P, Kennedy N, Ponta H, Rahmsdorf U, Hynes NE . Delimitation of a DNA sequence which confers inducibility by glucocorticoid hormones. J Cell Biochem 1982; 20: 349–357.

    Article  CAS  PubMed  Google Scholar 

  47. Grimm D . Production methods for gene transfer vectors based on adeno-associated virus serotypes. Methods 2002; 28: 146–157.

    Article  CAS  PubMed  Google Scholar 

  48. Grimm D, Kay MA, Kleinschmidt JA . Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 2003; 7: 839–850.

    Article  CAS  PubMed  Google Scholar 

  49. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973–985.

    Article  CAS  PubMed  Google Scholar 

  50. Bleker S, Sonntag F, Kleinschmidt JA . Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity. J Virol 2005; 79: 2528–2540.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Wrzesinski C, Tesfay L, Salome N, Jauniaux JC, Rommelaere J, Cornelis J et al. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells. J Virol 2003; 77: 3851–3858.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Faisst S, Perros M, Deleu L, Spruyt N, Rommelaere J . Mapping of upstream regulatory elements in the P4 promoter of parvovirus minute virus of mice. Virology 1994; 202: 466–470.

    Article  CAS  PubMed  Google Scholar 

  53. Gu Z, Plaza S, Perros M, Cziepluch C, Rommelaere J, Cornelis JJ . NF-Y controls transcription of the minute virus of mice P4 promoter through interaction with an unusual binding site. J Virol 1995; 69: 239–246.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Pereira DJ, McCarty DM, Muzyczka N . The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J Virol 1997; 71: 1079–1088.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Pereira DJ, Muzyczka N . The adeno-associated virus type 2 p40 promoter requires a proximal Sp1 interaction and a p19 CArG-like element to facilitate Rep transactivation. J Virol 1997; 71: 4300–4309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Weger S, Wistuba A, Grimm D, Kleinschmidt JA . Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. J Virol 1997; 71: 8437–8447.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Kyostio SR, Wonderling RS, Owens RA . Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J Virol 1995; 69: 6787–6796.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR . Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther 1995; 6: 1329–1341.

    Article  CAS  PubMed  Google Scholar 

  59. Tamayose K, Hirai Y, Shimada T . A new strategy for large-scale preparation of hightiter recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum Gene Ther 1996; 7: 507–513.

    Article  CAS  PubMed  Google Scholar 

  60. Fisher KJ, Gao G, Weitzman MD, DeMatteo R, Burda J, Wilson JM . Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520–532.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Ferrari FK, Samulski T, Shenk T, Samulski RJ . Second-strand synthesis is a ratelimiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996; 70: 3227–3234.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Xiao W, Warrington Jr KH, Hearing P, Hughes J, Muzyczka N . Adenovirus facilitated nuclear translocation of adeno-associated virus type 2. J Virol 2002; 76: 11505–11517.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Daeffler L, Horlein R, Rommelaere J, Nuesch JP . Modulation of minute virus of mice cytotoxic activities through site-directed mutagenesis within the NS coding region. J Virol 2003; 77: 12466–12478.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Caillet-Fauquet P, Perros M, Brandenburger A, Spegelaere P, Rommelaere J . Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. EMBO J 1990; 9: 2989–2995.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Corbau R, Duverger V, Rommelaere J, Nuesch JP . Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects. Virology 2000; 278: 151–167.

    Article  CAS  PubMed  Google Scholar 

  66. Mousset S, Ouadrhiri Y, Caillet-Fauquet P, Rommelaere J . The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression. J Virol 1994; 68: 6446–6453.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Kanazawa T, Urabe M, Mizukami H, Okada T, Kume A, Nishino H et al. Gamma-rays enhance rAAV-mediated transgene expression and cytocidal effect of AAVHSVtk/ganciclovir on cancer cells. Cancer Gene Ther 2001; 8: 99–106.

    Article  CAS  PubMed  Google Scholar 

  68. Peng D, Qian C, Sun Y, Barajas MA, Prieto J . Transduction of hepatocellular carcinoma (HCC) using recombinant adeno-associated virus (rAAV): in vitro and in vivo effects of genotoxic agents. J Hepatol 2000; 32: 975–985.

    Article  CAS  PubMed  Google Scholar 

  69. Kanazawa T, Mizukami H, Okada T, Hanazono Y, Kume A, Nishino H et al. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice. Gene Therapy 2003; 10: 51–58.

    Article  CAS  PubMed  Google Scholar 

  70. Russell DW, Alexander IE, Miller AD . DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors. Proc Natl Acad Sci USA 1995; 92: 5719–5723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Alexander J, Russell D, Miller A . DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 1994; 68: 8282–8287.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Alexander IE, Russell DW, Spence AM, Miller AD . Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum Gene Ther 1996; 7: 841–850.

    Article  CAS  PubMed  Google Scholar 

  73. Sanlioglu S, Benson P, Engelhardt JF . Loss of ATM function enhances recombinant adeno-associated virus transduction and integration through pathways similar to UV irradiation. Virology 2000; 268: 68–78.

    Article  CAS  PubMed  Google Scholar 

  74. Niculescu-Duvaz I, Springer CJ . Introduction to the background, principles, and state of the art in suicide gene therapy. Mol Biotechnol 2005; 30: 71–88.

    Article  CAS  PubMed  Google Scholar 

  75. Kashiwakura Y, Tamayose K, Iwabuchi K, Hirai Y, Shimada T, Matsumoto K et al. Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection. J Virol 2005; 79: 609–614.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Tullis GE, Burger LR, Pintel DJ . The minor capsid protein VP1 of the autonomous parvovirus minute virus of mice is dispensable for encapsidation of progeny singlestranded DNA but is required for infectivity. J Virol 1993; 67: 131–141.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Summerford C, Samulski RJ . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438–1445.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Summerford C, Bartlett JS, Samulski RJ . AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999; 5: 78–82.

    Article  CAS  PubMed  Google Scholar 

  79. Qing K, Mah C, Hansen J, Zhou S, Dwarki V, Srivastava A . Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999; 5: 71–77.

    Article  CAS  PubMed  Google Scholar 

  80. Akache B, Grimm D, Pandey K, Yant SR, Xu H, Kay MA . The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9. J Virol 2006; 80: 9831–9836.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Isayeva T, Kumar S, Ponnazhagan S . Anti-angiogenic gene therapy for cancer (review). Int J Oncol 2004; 25: 335–343.

    CAS  PubMed  Google Scholar 

  82. Qing K, Khuntirat B, Mah C, Kube DM, Wang XS, Ponnazhagan S et al. Adenoassociated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J Virol 1998; 72: 1593–1599.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Qing K, Wang XS, Kube DM, Ponnazhagan S, Bajpai A, Srivastava A . Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc Natl Acad Sci USA 1997; 94: 10879–10884.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Qing K, Hansen J, Weigel-Kelley KA, Tan M, Zhou S, Srivastava A . Adenoassociated virus type 2-mediated gene transfer: role of cellular fkbp52 protein in transgene expression. J Virol 2001; 75: 8968–8976.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Qing K, Li W, Zhong L, Tan M, Hansen J, Weigel-Kelley KA et al. Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo. J Virol 2003; 77: 2741–2746.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Bashir T, Horlein R, Rommelaere J, Willwand K . Cyclin A activates the DNA polymerase delta-dependent elongation machinery in vitro: a parvovirus DNA replication model. Proc Natl Acad Sci USA 2000; 97: 5522–5527.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Hillgenberg M, Schlehofer JR, von Knebel Doeberitz M, Klein-Bauernschmitt P . Enhanced sensitivity of small cell lung cancer cell lines to cisplatin and etoposide after infection with adeno-associated virus type 2. Eur J Cancer 1999; 35: 106–110.

    Article  CAS  PubMed  Google Scholar 

  88. Duverger V, Sartorius U, Klein-Bauernschmitt P, Krammer PH, Schlehofer JR . Enhancement of cisplatin-induced apoptosis by infection with adeno-associated virus type 2. Int J Cancer 2002; 97: 706–712.

    Article  CAS  PubMed  Google Scholar 

  89. Schwarzbach MH, Eisold S, Burguete T, Willeke F, Klein-Bauernschmitt P, Schlehofer JR et al. Sensitization of sarcoma cells to doxorubicin treatment by concomitant wild-type adeno-associated virus type 2 (AAV-2) infection. Int J Oncol 2002; 20: 1211–1218.

    CAS  PubMed  Google Scholar 

  90. Kuntz-Simon G, Bashir T, Rommelaere J, Willwand K . Neoplastic transformation-associated stimulation of the in vitro resolution of concatemer junction fragments from minute virus of mice DNA. J Virol 1999; 73: 2552–2558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Nuesch JP, Rommelaere J . NS1 interaction with CKII alpha: novel protein complex mediating parvovirus-induced cytotoxicity. J Virol 2006; 80: 4729–4739.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  92. Ding W, Zhang L, Yan Z, Engelhardt JF . Intracellular trafficking of adeno-associated viral vectors. Gene Therapy 2005; 12: 873–880.

    Article  CAS  PubMed  Google Scholar 

  93. Vihinen-Ranta M, Suikkanen S, Parrish CR . Pathways of cell infection by parvoviruses and adeno-associated viruses. J Virol 2004; 78: 6709–6714.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Hauck B, Zhao W, High K, Xiao W . Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction. J Virol 2004; 78: 13678–13686.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Nakai H, Yant SR, Storm TA, Fuess S, Meuse L, Kay MA . Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J Virol 2001; 75: 6969–6976.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Wu Z, Asokan A, Samulski RJ . Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther 2006; 14: 316–327.

    Article  CAS  PubMed  Google Scholar 

  97. Gao G, Vandenberghe LH, Wilson JM . New recombinant serotypes of AAV vectors. Curr Gene Ther 2005; 5: 285–297.

    Article  CAS  PubMed  Google Scholar 

  98. Choi VW, McCarty DM, Samulski RJ . AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther 2005; 5: 299–310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Perabo L, Endell J, King S, Lux K, Goldnau D, Hallek M et al. Combinatorial engineering of a gene therapy vector: directed evolution of adeno-associated virus. J Gene Med 2006; 8: 155–162.

    Article  CAS  PubMed  Google Scholar 

  100. Maheshri N, Koerber JT, Kaspar BK, Schaffer DV . Directed evolution of adenoassociated virus yields enhanced gene delivery vectors. Nat Biotechnol 2006; 24: 198–204.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Applied Tumour Virology, German Cancer Research Centre, Heidelberg, Germany

    L Krüger, C Dinsart, J Cornelis, J Rommelaere & J A Kleinschmidt

  2. Department of Nuclear Medicine, Clinical Cooperation Unit Nuclear Medicine, University of Heidelberg, Heidelberg, Germany

    H Eskerski & U Haberkorn

Authors
  1. L Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Eskerski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Dinsart
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Cornelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Rommelaere
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U Haberkorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J A Kleinschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J A Kleinschmidt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krüger, L., Eskerski, H., Dinsart, C. et al. Augmented transgene expression in transformed cells using a parvoviral hybrid vector. Cancer Gene Ther 15, 252–267 (2008). https://doi.org/10.1038/sj.cgt.7701113

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7701113

Keywords

Search

Advanced search

Quick links